Golden Triangle gets £75M in fresh venture funds for Cambridge U spinouts
Today’s edition of Endpoints includes a new startup in a booming Kendall Square and a $1 billion-plus biotech campus for South San Francisco. So let’s wind up with some upbeat news for that other Cambridge biotech cluster — in the UK.
Cambridge Innovation Capital, which is charged with funding spinouts from the famously storied university, has raised £75 million, or close to $100 million after you put it through a post-Brexit conversion. That’s more than twice what the CIC group has invested so far, and biotech will be a key focus.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.